This site is intended for healthcare professionals only
LoginRegister
Strides Pharma Recalls Testosterone Gel In US MarketStrides Pharma Science Singapore arm to acquire 100 percent stake in Amexel
Not a Nice Time For Dr Reddys? DTAB, CDSCO Recommends Stringent Restrictions on NimesulideDr Reddy's Labs recalls epilepsy drug in US over infusion bag mislabeling
Bayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular carcinoma patientsBayer Finerenone secures USFDA Priority Review designation for heart failure
Alkem Labs completes acquisition of 100% stake in Adroit BiomedAstraZeneca to acquire EsoBiotec for up to USD 1 billion
Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issuesSun Pharma, Zydus recall products in US over manufacturing issues
USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoeaUSFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoea
Lupin bags tentative USFDA nod for rare autoimmune disorder drug AmifampridineLupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine
AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancerAstraZeneca Imfinzi approved in EU for limited stage small cell lung cancer
Not a Nice Time For Dr Reddys? DTAB, CDSCO Recommends Stringent Restrictions on NimesulideDr Reddy's Laboratories gets CDSCO Panel nod to study Rabeprazole Sodium Modified Release Capsules
Novartis to acquire kidney disease drug maker Regulus Therapeutics for up to 1.7 billionCDSCO Panel Approves Updated Package Insert for Novartis' Ofatumumab Injection
As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In IndiaNo Long-Term Safety Data: CDSCO Panel Denies Novo Nordisk's proposal to amend warning statement of...
DoP organises Industry dialogue on PRIP Scheme in MumbaiDoP organises Industry dialogue on PRIP Scheme in Mumbai
X